Similar articles

• [Choice of recipent in human cardiac transplantation].

  Gandjbakhch I, Rottembourg J, Conseiller C, Mattei MF, Christides C, Guiraudon G, Cabrol C, Cabrol A. Gandjbakhch I, et al. Nouv Presse Med. 1975 Mar 22;4(12):867-70. Nouv Presse Med. 1975. PMID: 1094777 French.
• [Lymphomas after kidney allotransplantation].

  Kleĭza V, Stanaĭtite N, Daĭnis B. Kleĭza V, et al. Urol Nefrol (Mosk). 1978 Mar-Apr;(2):54-9. Urol Nefrol (Mosk). 1978. PMID: 347667 Russian. No abstract available.
• Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation.

  Anderson JL, Fowles RE, Bieber CP, Stinson EB. Anderson JL, et al. Lancet. 1978 Dec 2;2(8101):1174-7. doi: 10.1016/s0140-6736(78)92156-6. Lancet. 1978. PMID: 82142
• [Surgical management of cardiovascular disorders, therapy and results: heart transplantation].

  Sebening F. Sebening F. Verh Dtsch Ges Kreislaufforsch. 1970;36:173-81. Verh Dtsch Ges Kreislaufforsch. 1970. PMID: 4927225 Review. German. No abstract available.
• [Cardiac transplantation : current contraindications and alternative therapies].

  Seydoux C. Seydoux C. Rev Med Suisse Romande. 2002 Mar;122(3):131-5. Rev Med Suisse Romande. 2002. PMID: 12014250 Review. French. No abstract available.